Pfizer Inc. (NYSE:PFE) traded today at a new 52-week high of $42.07. So far today approximately 45 million shares have been exchanged, as compared to an average 30-day volume of 49.5 million shares.
Over the past year, Pfizer Inc. has traded in a range of $27.88 to $42.07 and is now at $41.18, 48% above that low.
Pfizer is one of the world’s largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually.
There is potential upside of 87.4% for shares of Pfizer Inc. based on a current price of $41.18 and an average consensus analyst price target of $77.18.
Receive IBN Spotlights – “Bit Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN alerts, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer